To define the biology and molecular mechanisms of USP22 in NSCLC, we performed RNA-seq to profile global gene expression change upon USP22 knockout in A549 (p53 wild-type, KRAS/G12S) and H1299 cancer cells (p53-null, NRAS/Q61K). This evidence concerns the gene TP53 and cancer.